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MicroRNAs modulate target gene expression and are essential for normal development, but how does this
pathway impact cell fate decisions? In this issue of Cell Stem Cell, Ivey et al. (2008) find that muscle-specific
microRNAs repress nonmuscle genes to direct embryonic stem cell differentiation to mesoderm andmuscle.Pluripotent embryonic stem (ES) cells are
capable of differentiating to all possible
cell types. This unique property promises
future medical applications, but to fulfill
this potential it will be necessary to con-
trol ES cell differentiation. Much progress
has been made toward understanding the
role of signaling pathways and transcrip-
tion factors for these cell fate choices,
yet our current understanding remains in-
complete. Until now, the role of individual
microRNAs (miRNAs) remained largely
unaddressed. miRNAs comprise a large
family of regulatory RNAs with critical
roles in diverse developmental and phys-
iological pathways (Kloosterman and
Plasterk, 2006). Sequential cleavage of
long primary transcripts by the Micropro-
cessor and Dicer complexes yields ma-
ture 22 nucleotide miRNAs that direct
messenger RNA cleavage or translational
repression (Eulalio et al., 2008). Mouse ES
cells lacking miRNAs are unable to down-
regulate pluripotency markers after in-
duction of differentiation and retain the
ability to produce ES cell colonies (Kloos-
terman and Plasterk, 2006). Therefore,
an important question is how individual
miRNAs contribute to cell differentiation.
In this issue, Ivey and colleagues demon-
strate a new role for miRNAs in regulating
EScell differentiation. They find thatmiR-1
and miR-133 direct mesoderm forma-
tion and regulate differentiation to cardiac
muscle by suppressing gene expression
of alternative lineages (Ivey et al., 2008).
Ivey et al. began by identifying miRNAs
that are enriched in cardiac progenitors
derived from in vitro-differentiated mouse
ES cells. Using fluorescence-activated
cell sorting (FACS) they isolated purified
cell populations expressing a b-myosin-
driven green fluorescent protein (GFP)and performed miRNA expression profil-
ing using microarrays. Comparison of
GFP+ and GFP cells collected from dif-
ferentiated embryoid bodies (EBs) re-
vealed nine miRNAs enriched in cardiac
progenitors and undetectable in undiffer-
entiated ES cells. Among this list were
miR-1 and miR-133, muscle-specific
miRNAs that are important for heart devel-
opment and physiology (Chen et al., 2006;
Zhao et al., 2007). Next, to investigate the
function of miR-1 and miR-133 in ES cell
differentiation the authors used lentivi-
ruses to introduce these miRNAs and de-
rived stable ES cell lines expressing the in-
dividualmiRNAs. Interestingly, expression
of either of these miRNAs alone was in-
sufficient to drive ES cell differentiation.
However,duringembryoidbody formation,
expression of either miR-1 or miR-133
led todramatically increased levels of early
mesoderm markers. Importantly, this in-
crease in mesoderm gene expression
was due to an increased number of ex-
pressing cells as well as increased levels
per cell, suggesting that both miRNAs
promote mesoderm formation. However,
whereas miR-1 also promoted further dif-
ferentiation to cardiac and skeletal mus-
cle, expression of miR-133 had an inhibi-
tory effect on myogenesis. Therefore,
these in vitro ES cell differentiation assays
largely recapitulate several aspects of
miR-1 and miR-133 function in vivo
(Chen et al., 2006; Zhao et al., 2007). One
major conundrum is that miR-1 and miR-
133 have opposing roles in cardiac devel-
opment, yet they are processed from the
sameprimary transcript. Therefore, unless
unidentified mechanisms exist to selec-
tively regulate the biogenesis of these
miRNAs, they should be coexpressed in
individual cells. It will therefore be impor-Cell Stemtant to identify the mechanisms that can
explain this apparent discrepancy.
How does expression of these miRNAs
enhance mesoderm formation? One pos-
sibility is that they could increase the pro-
portion of cells expressing mesodermal
mRNAs by suppressing differentiation
into alternative lineages. To test this hy-
pothesis, the authors compared gene
expressionprofilesofwild-typeandmiR-1-
and miR-133-expressing cells by mi-
croarray analyses. Expression of markers
associated with endoderm specification
and differentiation was significantly lower
in the miRNA-expressing cells. Interest-
ingly, markers associated with neuroecto-
derm specification were upregulated with
a corresponding decrease in markers of
differentiated neurons. Ivey et. al further
examined the repression of neuroecto-
derm differentiation in a more in vivo
setting using teratoma formation assays.
Indeed, compared to control teratomas,
those derived from miR-1- and miR-133-
expressing ES cells had more neuronal
progenitor cells, but were dramatically
depleted of differentiated neuronal cells.
The physiological relevance of promoting
neuronal, but not endoderm, progenitor
cells by these muscle-specific miRNAs
is not clear, but it certainly warrants fur-
ther investigation. Nevertheless, it is clear
that both miRNAs suppress cell differenti-
ation into nonmuscle lineages. Further-
more, bothmiRNAs seemed to have com-
parable functions in human ES cells.
Because Notch signaling can promote
neural differentiation and inhibit muscle
differentiation in ES cells (which is oppo-
site to the effects of miR-1 expression),
together with their previous identification
of the Notch ligand delta as the major
effector of miR-1 function in flies, IveyCell 2, March 2008 ª2008 Elsevier Inc. 195
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Previewset al. asked whether mouse
delta homologs are also un-
der the same control. They
showed that among three
mouse homologs of delta,
only Dll-1 is regulated by
miR-1. Importantly, ablation
of Dll-1 by shRNA mimicked
the effects of ectopic miR-1
expression in ES cells, such
that EBs formed from Dll-1-
depleted ES cells had a
greater propensity towardcar-
diomyocyte differentiation.
How do miRNAs control ES
cell self-renewal and differen-
tiation? First, though a few
ES cell-specific miRNAs have
been identified, their function
awaits elucidation (Houbaviy
et al., 2003). However,
miRNA-deficient ES cells ex-
hibit delayed cell-cycle pro-
gression, suggesting that
certain miRNA(s) may be im-
portant for ES cell prolifera-
tion (Kloosterman and Plas-
terk, 2006). Second, miRNAs
can initiate differentiation.
For example, ectopic let-7
expression causes cancer
stem and progenitor cells to
differentiate, while let-7 de-
pletion enhances self-re-
newal of those cells (Ibarra
et al., 2007; Yu et al., 2007). Because
let-7 levels increase upon ES cell differen-
tiation, it is likely that let-7 also promotes
ES cell differentiation. Finally, Ivey et al.
demonstrated that tissue-specific miR-
NAs direct differentiation toward corre-
sponding lineages by suppressing alter-
native cell fates (Figure 1). This concept
may be widely applicable, because it
was previously reported that ectopic ex-
pression of muscle (miR-1)- and brain
(miR-124)-specific miRNAs in HeLa cells
caused global shifts in gene expression
toward patterns observed in the appropri-
ate tissues (Lim et al., 2005). A compre-
hensive profiling of miRNA expressions
in different tissues has recently been
completed (Landgraf et al., 2007). It will
be of great interest to determine whether
other tissue-specific miRNAs function in
a similar fashion to direct differentiation
into corresponding lineages. Perhaps, uti-
lizing the right combination
of miRNAs to reinforce cell
fate decisions will facilitate
the generation of homoge-
neous cell populations of de-
sired lineages from ES cells,
and may be therapeutically
exploited.
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Figure 1. Potential Roles of Different miRNAs in Embryonic Stem
Cell Self-Renewal and Differentiation
(A) Though not essential for ES cell viability, miRNAs are important for normal
cell-cycle progression and stem cell proliferation. The particular miRNA or
miRNAs important for this regulation have yet to be defined.
(B) The developmentally regulated let-7 family miRNAs promote stem cell
differentiation and may act by repressing expression of the self-renewal
machinery.
(C) miR-1 and miR-133 do not initiate ES cell differentiation but rather direct
cell fate choices through the repression of alternative cell lineage gene
expression.196 Cell Stem Cell 2, March 2008 ª2008 Elsevier Inc.
